Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00902
|
|||||
| Drug Name |
Baicalin
|
|||||
| Synonyms |
(2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; 21967-41-9; 31564-28-0; 347Q89U4M5; 5,6,7-trihydroxyflavone 7-O-beta-D-glucuronide; 5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid; 7-D-Glucuronic acid-5,6-dihydroxyflavone; BAICAILIN; Baicalein 7-O-glucuronide; Baicalin; Baicalin hydrate; CHEBI:2981; CHEMBL485818; UNII-347Q89U4M5; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H18O11
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O
|
|||||
| InChI |
InChI=1S/C21H18O11/c22-9-6-10(8-4-2-1-3-5-8)30-11-7-12(14(23)15(24)13(9)11)31-21-18(27)16(25)17(26)19(32-21)20(28)29/h1-7,16-19,21,23-27H,(H,28,29)/t16-,17-,18+,19-,21+/m0/s1
|
|||||
| InChIKey |
IKIIZLYTISPENI-ZFORQUDYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 446.4 | Topological Polar Surface Area | 183 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 11 | |||
| XLogP |
1.1
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.